Recent studies showed that glioblastoma-derived exosomal LGALS9 suppresses dendritic cell (DC) antigen presentation and cytotoxic T cell immunity in cerebrospinal fluid (CSF), providing a mechanistic basis for the profound immune dysfunction observed in glioblastoma [24,25]. Here, LGALS9 is linked to glioblastoma.